Osteoporosis[Mesh] AND Glucocorticoids[Mesh] - Search Results

Year	Number of Results
1965	1
1967	1
1968	1
1970	1
1974	1
1986	1
1993	2
1994	1
1995	2
1996	1
1997	6
1998	8
1999	5
2000	8
2001	5
2002	9
2003	16
2004	7
2005	7
2006	10
2007	13
2008	6
2009	19
2010	25
2011	19
2012	16
2013	25
2014	22
2015	22
2016	26
2017	26
2018	40
2019	29
2020	33
2021	33
2022	38
2023	41
2024	34
2025	39
2026	16

1

A Plant-Derived Flavonoid, Isobavachin, Promotes Osteogenesis and Alleviates Glucocorticoid-Induced Osteoporosis via Modulation of the ESR1-PI3K/Akt Signaling Pathway.

Cui J, Song X, Liu H, Cui Z, Sun M, He M, Jin M. Cui J, et al. Molecules. 2026 Jun 18;31(12):2158. doi: 10.3390/molecules31122158. Molecules. 2026. PMID: 42357555 Free PMC article.

2

Update on Glucocorticoid-Induced Osteoporosis: Emerging Therapeutic Strategies.

Cho SK, Sung YK. Cho SK, et al. Endocrinol Metab (Seoul). 2026 Jun;41(3):358-366. doi: 10.3803/EnM.2026.3006. Epub 2026 Jun 16. Endocrinol Metab (Seoul). 2026. PMID: 42298757 Free PMC article. Review.

3

Role of Prednisone and 25-Hydroxyvitamin D on Bone Mineral Density and Osteoporosis in Systemic Lupus Erythematosus.

Madanchi N, Fava A, Goldman DW, Magder LS, Petri M. Madanchi N, et al. Arthritis Care Res (Hoboken). 2026 Jun;78(6):743-748. doi: 10.1002/acr.25701. Epub 2026 Jan 30. Arthritis Care Res (Hoboken). 2026. PMID: 41310941 Free PMC article.

4

Comparable Protective Effects of Low- and High-Dose MK-7 on Bone Structure and Remodeling in a Rat Model of Osteoporosis Induced by Estrogen Deficiency and Glucocorticoid Exposure.

Chiang HJ, Hsu SY, Leu S. Chiang HJ, et al. Nutrients. 2026 May 18;18(10):1605. doi: 10.3390/nu18101605. Nutrients. 2026. PMID: 42197064 Free PMC article.

5

The effect of pulse steroid therapy on bone density and turnover: A systematic review and meta-analysis.

Law LS, Siddiqui F, Al-Aamri A, Chionh SB, Eng PC, Khoo CM. Law LS, et al. Ann Acad Med Singap. 2026 May 14;55(5):189-200. doi: 10.47102/annals-acadmedsg.2026123. Ann Acad Med Singap. 2026. PMID: 42142321 Free article.

6

Changes in bone mineral density and fractures during 2 years of low-dose glucocorticoid treatment for rheumatoid arthritis: a systematic literature review and individual participant data meta-analysis.

Palmowski A, Haugegaard T, Hafström I, Bliddal H, Oldenkott J, Wassenberg S, Choy E, Kirwan J, Christensen R, Boers M, Buttgereit F. Palmowski A, et al. RMD Open. 2026 May 7;12(2):e006615. doi: 10.1136/rmdopen-2025-006615. RMD Open. 2026. PMID: 42097691 Free PMC article.

7

[Jintiange Capsule alleviates glucocorticoid-induced osteoporosis in rats by inhibiting vascular endothelial cell senescence and promoting bone formation].

Deng Z, Wang Z, Meng S, Yang Y, Yang Y, Fan L, Wang L. Deng Z, et al. Nan Fang Yi Ke Da Xue Xue Bao. 2026 Apr 20;46(4):861-870. doi: 10.12122/j.issn.1673-4254.2026.04.14. Nan Fang Yi Ke Da Xue Xue Bao. 2026. PMID: 42045036 Free PMC article. Chinese.

8

Spatholobus suberectus Stem-Derived Extracellular Vesicle-Like Particles Attenuate Glucocorticoid-Induced Osteoporosis via NRF2/HO-1 Signaling.

Chen G, Li H, Chen R, Yao Y, Lian G, Bai L, Chen H, Zhang C, Chen G. Chen G, et al. Int J Nanomedicine. 2026 Apr 11;21:585928. doi: 10.2147/IJN.S585928. eCollection 2026. Int J Nanomedicine. 2026. PMID: 41993783 Free PMC article.

9

piR-27222 alleviates dexamethasone-induced osteoporosis by inhibiting ferroptosis through modulating WWP1.

Dai Y, Wen X, Li D, Chen M. Dai Y, et al. J Orthop Surg Res. 2026 Mar 26;21(1):295. doi: 10.1186/s13018-026-06793-5. J Orthop Surg Res. 2026. PMID: 41888816 Free PMC article.

10

5-HMF inhibits glucocorticoid-induced osteoporosis through the VEGFR2/PI3K/AKT pathway.

Liu S, Fang F, Jiang Y. Liu S, et al. Sci Rep. 2026 Mar 18;16(1):13986. doi: 10.1038/s41598-026-44463-y. Sci Rep. 2026. PMID: 41851359 Free PMC article.

11

The risk of osteoporosis in COPD: An analysis of sex differences and mediating effects based on NHANES.

Gao Y, Li Z, Wu J, Du L, Min M, Li L, Chen X, Zhong Z, Chen S. Gao Y, et al. NPJ Prim Care Respir Med. 2026 Mar 7;36(1):26. doi: 10.1038/s41533-026-00490-w. NPJ Prim Care Respir Med. 2026. PMID: 41794937 Free PMC article.

12

Ascorbic Acid Modulates Collagen Properties in Glucocorticoid-Induced Osteoporotic Bone: Insights into Chemical, Mechanical, and Biological Regulation.

Curtis M, Kim Y, Patil R, Zhang X, Jayatilake M, Bulgin O, Lialios P, Surrency S, Tarrah S, Lazaris AK, Grafton A, Williams J 4th, Nouraie SB, Bizaki M, Xeron P, Van Keuren E, Seppala JE, Laiakis EC, Kitlinska JB, Alimperti S. Curtis M, et al. Adv Healthc Mater. 2026 Mar;15(12):e02606. doi: 10.1002/adhm.202502606. Epub 2025 Sep 25. Adv Healthc Mater. 2026. PMID: 40995752 Free PMC article.

13

Fracture risk tools performance and potential use in systemic lupus erythematosus.

Aldegheri F, Rotta D, Galvagni I, Pistillo F, Fassio A, Gatti D, Zen M, Ravagnani V, Maiolini F, Croce J, Volpe A, Dartizio C, Benini C, Ruzzon F, Viapiana O, Rossini M, Orsolini G, Adami G. Aldegheri F, et al. Lupus Sci Med. 2026 Feb 9;13(1):e001904. doi: 10.1136/lupus-2025-001904. Lupus Sci Med. 2026. PMID: 41663157 Free PMC article.

14

The effects of steroid treatment on osteoporosis in patients with inflammatory bowel disease: A systematic review and meta-analysis.

Li CC, Xu LP, Zheng TT, Wu XL. Li CC, et al. Medicine (Baltimore). 2026 Jan 16;105(3):e47173. doi: 10.1097/MD.0000000000047173. Medicine (Baltimore). 2026. PMID: 41560068 Free PMC article.

15

The Danish Nationwide osteoporosis cohort trials environment (NOCTE) - a DXA dataset for the 1900-1960 birth cohort.

Hansen BB, Haddock B, Jørgensen NR, Vestergaard P, Wiil UK, Folkestad L, Möller S, Fuggle N, Langdahl B, Rubin KH, Abrahamsen B. Hansen BB, et al. J Clin Densitom. 2026 Jan-Mar;29(1):101653. doi: 10.1016/j.jocd.2025.101653. Epub 2025 Nov 12. J Clin Densitom. 2026. PMID: 41317664 Free article.

16

Endocrinological complications of Duchenne muscular dystrophy and their subjective burden: observational study evaluating growth, puberty, and bone health.

Rohlenova M, Haberlova J, Holotova P, Kumhera M, Simkova L, Lauerova B, Svabova I, Soucek O. Rohlenova M, et al. J Endocrinol Invest. 2026 Jan;49(1):119-130. doi: 10.1007/s40618-025-02699-x. Epub 2025 Sep 16. J Endocrinol Invest. 2026. PMID: 40956566 Free PMC article.

17

Vitamin K₂ Protects Against Glucocorticoid-Induced Osteoporosis by Activating the NRF2/FSP1 Pathway to Inhibit Osteoblast Ferroptosis.

Zhang Z, Rong X, Ren Q, Kou Y, Guo J, Li M. Zhang Z, et al. Drug Des Devel Ther. 2025 Dec 23;19:11525-11545. doi: 10.2147/DDDT.S554610. eCollection 2025. Drug Des Devel Ther. 2025. PMID: 41458254 Free PMC article.

18

High doses of methylprednisolone causes substantial muscle loss with minimal impact on bone mass and architecture in C57BL/6JRj and RjOrl:SWISS mice.

Slavensky OL, Bromer FD, Thomsen JS, Brüel A. Slavensky OL, et al. Sci Rep. 2025 Dec 7;16(1):333. doi: 10.1038/s41598-025-29729-1. Sci Rep. 2025. PMID: 41354760 Free PMC article.

19

The N-butanol extract of modified Yanghe decoction alleviates ferroptosis in bone marrow mesenchymal stem cells in glucocorticoid-induced osteoporosis by activating the HIF-1α/GPX4 signaling pathway.

Yang F, Wu F, Liu J, Cao D, Yang W, Xia H. Yang F, et al. J Orthop Surg Res. 2025 Nov 28;20(1):1049. doi: 10.1186/s13018-025-06404-9. J Orthop Surg Res. 2025. PMID: 41316326 Free PMC article.

20

Up-regulation of Ifi27l2a expression in bone marrow monocytes contributes to glucocorticoid-induced bone loss.

Wang Z, Huang C, Liu S, Xiao P, Lu Z, Xu Y, Tian Y. Wang Z, et al. Commun Biol. 2025 Nov 17;8(1):1590. doi: 10.1038/s42003-025-08985-x. Commun Biol. 2025. PMID: 41249558 Free PMC article.

21

Glucocorticoid-induced osteoporosis: novel concepts and clinical implications.

Hofbauer LC, Compston JE, Saag KG, Rauner M, Tsourdi E. Hofbauer LC, et al. Lancet Diabetes Endocrinol. 2025 Nov;13(11):964-979. doi: 10.1016/S2213-8587(25)00251-7. Epub 2025 Sep 26. Lancet Diabetes Endocrinol. 2025. PMID: 41022095 Free article. Review.

22

Exploring the natural history of bone mineral density in Duchenne muscular dystrophy: a systematic literature review.

De Ford C, Guridi M, Chen Y, Murphy AP, Wood C, McMillan HJ, Mercuri E, Crabtree N, Ward L. De Ford C, et al. Osteoporos Int. 2025 Nov;36(11):2097-2113. doi: 10.1007/s00198-025-07651-6. Epub 2025 Aug 29. Osteoporos Int. 2025. PMID: 40879743 Free PMC article.

23

Comparative Bone-Protective Effects of Tocotrienol Isomers from Palm and Annatto in Dexamethasone-Induced Osteoporotic Male Rats.

Ramli ESM, Ahmad F, Kamaruddin NA, Chin KY, Soelaiman IN, Pang KL. Ramli ESM, et al. Int J Mol Sci. 2025 Oct 20;26(20):10206. doi: 10.3390/ijms262010206. Int J Mol Sci. 2025. PMID: 41155499 Free PMC article.

24

Antiresorptive effect of a semisynthetic triterpene from Combretum leprosum Mart. on dexamethasone-induced osteoporosis in rats.

Garcez LR, Goes P, Cavalcante JLT, Costa SAD, Ribeiro WLC, Pereira KMA, Costa FWG, Silva PGB, Carvalho FSR, Silva-Filho CJA, Capistrano ALO, Rauner M, Thiele S, Barbosa FG, Mafezoli J, Chaves HV, Leitão RFC, Vasconcelos RF, Bezerra MM. Garcez LR, et al. Braz J Med Biol Res. 2025 Oct 17;58:e14833. doi: 10.1590/1414-431X2025e14833. eCollection 2025. Braz J Med Biol Res. 2025. PMID: 41124444 Free PMC article.

25

Bone Mineral Density in Patients With Congenital Adrenal Hyperplasia From Prepubertal to Adult Age.

Stancampiano MR, Pitea M, Maruca K, Meroni SLC, Bucolo C, Russo G, Mora S. Stancampiano MR, et al. J Clin Endocrinol Metab. 2025 Oct 16;110(11):e3850-e3856. doi: 10.1210/clinem/dgaf123. J Clin Endocrinol Metab. 2025. PMID: 39996431 Free article.

26

YS-49 activates the PI3K/AKT signaling pathway in MC3T3-E1 cells to enhance osteoblast differentiation and inhibits glucocorticoid-induced bone loss in vivo.

Cao Y, Yu Y, Wang F, Zhang K, Jiang Z, Kang Q, Xu J. Cao Y, et al. BMC Musculoskelet Disord. 2025 Oct 14;26(1):961. doi: 10.1186/s12891-025-09167-w. BMC Musculoskelet Disord. 2025. PMID: 41088103 Free PMC article.

27

Targeting SIRT3 to regulate mitophagy-dependent ferroptosis for preventing glucocorticoid-induced osteoporosis.

Hu Y, Lu H, Fang H, Chen B, Chen Z, Jiang M, Zhou Y, Li Z, Gao S, Huang Z, Zhou C, Liu Y, Chen Z, Fan Y. Hu Y, et al. Int J Surg. 2025 Oct 1;111(10):6647-6662. doi: 10.1097/JS9.0000000000002783. Epub 2025 Jul 1. Int J Surg. 2025. PMID: 40607908 Free PMC article.

28

Prevalence and determinants of vertebral fractures in a SLE cohort.

Rotta D, Adami G, Galvagni I, Pistillo F, Fassio A, Gatti D, Zen M, Ravagnani V, Maiolini F, Croce J, Volpe A, Dartizio C, Benini C, Ruzzon F, Viapiana O, Rossini M, Orsolini G. Rotta D, et al. Lupus Sci Med. 2025 Sep 14;12(2):e001508. doi: 10.1136/lupus-2025-001508. Lupus Sci Med. 2025. PMID: 40953912 Free PMC article.

29

Unraveling Ginsenoside Rg1's osteoprotective pathways in zebrafish models of glucocorticoid induced osteoporosis via transcriptomics.

Fan X, Zhang Y, Li X, Ding J, Huang J, Lian K, Duan P, Hu C, Xu J. Fan X, et al. Sci Rep. 2025 Aug 20;15(1):30519. doi: 10.1038/s41598-025-15284-2. Sci Rep. 2025. PMID: 40835685 Free PMC article.

30

Basigin links altered skeletal stem cell lineage dynamics with glucocorticoid-induced bone loss and impaired angiogenesis.

Ambrosi TH, Morales D, Chen K, Hunt EJ, Weldon KC, Maifeld AN, Chavez FIM, Wang Y, Zhao L, Wang L, Murphy MP, Cressman A, Wheeler EE, Saiz AM, Leach JK, Fierro FA, Chan CKF, Lane NE. Ambrosi TH, et al. Nat Commun. 2025 Aug 15;16(1):7606. doi: 10.1038/s41467-025-62881-w. Nat Commun. 2025. PMID: 40817087 Free PMC article.

31

PSMD14 Stabilizes SLC7A11 to Ameliorate Glucocorticoid-Induced Osteoporosis by Suppressing Osteocyte Ferroptosis.

Shi Y, Tang Q, Sheng S, Jiang H, Jin C, Zhou C, Xie C, Zheng L, Zhang D, Xu H, Xu C, Ma H, Xiang G, Ni W, Pan X, Yang L, Xu H, Qian Y, Wu A, Wang X, Zheng G. Shi Y, et al. Adv Sci (Weinh). 2025 Aug;12(31):e14902. doi: 10.1002/advs.202414902. Epub 2025 May 30. Adv Sci (Weinh). 2025. PMID: 40444470 Free PMC article.

32

Glucocorticoid-induced osteoporosis in children: emerging vascular and molecular targets.

Barik SK, Crane JL. Barik SK, et al. Curr Opin Pediatr. 2025 Aug 1;37(4):390-397. doi: 10.1097/MOP.0000000000001476. Epub 2025 Jun 2. Curr Opin Pediatr. 2025. PMID: 40441716 Free PMC article. Review.

33

Biological Heterogeneity in Susceptibility to Glucocorticoid-Induced Bone Loss: Short- and Long-Term Hip BMD Trajectories.

Hansen BB, Hass Rubin K, Vind Nielsen C, Frost Nielsen M, Hermann AP, Abrahamsen B. Hansen BB, et al. J Clin Endocrinol Metab. 2025 Jul 15;110(8):e2570-e2582. doi: 10.1210/clinem/dgae832. J Clin Endocrinol Metab. 2025. PMID: 39671259 Free PMC article.

34

Comparison of Efficacy of Romosozumab With Denosumab and Risedronate in Patients Newly Initiating Glucocorticoid Therapy.

Kawazoe M, Kaneko K, Masuoka S, Yamada S, Yamada Z, Muraoka S, Furukawa K, Sato H, Watanabe E, Koshiba K, Irita I, Kanaji M, Sugihara T, Nishio J, Nanki T. Kawazoe M, et al. J Clin Endocrinol Metab. 2025 Jul 15;110(8):e2778-e2786. doi: 10.1210/clinem/dgae810. J Clin Endocrinol Metab. 2025. PMID: 39552045 Free article. Clinical Trial.

35

Risk factors for glucocorticoid induced osteoporosis in young adults.

Florez H, Carrasco JL, Barberá M, Hernández-Rodríguez J, Muxi A, Mocritcaia A, Prieto-González S, Cid MC, Monegal A, Guañabens N, Peris P. Florez H, et al. Front Endocrinol (Lausanne). 2025 Jul 11;16:1528962. doi: 10.3389/fendo.2025.1528962. eCollection 2025. Front Endocrinol (Lausanne). 2025. PMID: 40717802 Free PMC article.

36

Tectorigenin Ameliorates Glucocorticoid-Induced Osteoporosis by Inhibiting the NF-κB Signal Pathway and Modulating Treg-Th17 Cell Balance.

Peng P, Wong P, Lv Z, Tian J, He W, Wei Q, Mo H, He M. Peng P, et al. J Cell Mol Med. 2025 Jul;29(13):e70705. doi: 10.1111/jcmm.70705. J Cell Mol Med. 2025. PMID: 40619720 Free PMC article.

37

Advances in the study and treatment of glucocorticoid osteoporosis: A review.

Song X, Zhang Y, Yang H, Xiong F, Chen F. Song X, et al. Medicine (Baltimore). 2025 May 30;104(22):e42668. doi: 10.1097/MD.0000000000042668. Medicine (Baltimore). 2025. PMID: 40441201 Free PMC article. Review.

38

Parthenolide ameliorates glucocorticoid-induced inhibition of osteogenic differentiation and osteoporosis by activating ERK signaling pathway.

Feng Y, Li Z. Feng Y, et al. J Orthop Surg Res. 2025 May 9;20(1):450. doi: 10.1186/s13018-025-05722-2. J Orthop Surg Res. 2025. PMID: 40346551 Free PMC article.

39

Increased risk of osteoporotic fractures and osteoporosis in patients with Addison's disease in Sweden: A nationwide population-based cohort study.

Stergianos S, Spelman T, Eriksson D, Öster S, Björnsdottir S, Kämpe O, Skov J, Bensing S. Stergianos S, et al. J Intern Med. 2025 May;297(5):518-531. doi: 10.1111/joim.20085. Epub 2025 Apr 6. J Intern Med. 2025. PMID: 40190018 Free PMC article.

40

Human umbilical cord mesenchymal stem cell-derived exosomes promote osteogenesis in glucocorticoid-induced osteoporosis through PI3K/AKT signaling pathway-mediated ferroptosis inhibition.

Zhao ZM, Ding JM, Li Y, Wang DC, Kuang MJ. Zhao ZM, et al. Stem Cells Transl Med. 2025 Mar 18;14(3):szae096. doi: 10.1093/stcltm/szae096. Stem Cells Transl Med. 2025. PMID: 40257841 Free PMC article.

41

Osteoporosis is associated with anti-topoisomerase I positivity and glucocorticoids use in patients with systemic sclerosis.

Midol C, Wiebe E, Siegert E, Huscher D, Béhal H, Launay D, Hachulla E, Matteson EL, Buttgereit F, Sobanski V. Midol C, et al. Rheumatology (Oxford). 2025 Mar 1;64(3):1270-1276. doi: 10.1093/rheumatology/keae142. Rheumatology (Oxford). 2025. PMID: 38452356 Free article.

42

Case series: Chemical pneumonitis caused by exposure of sodium ibandronate powder.

Pan T, Ma G, Qian J. Pan T, et al. Front Public Health. 2025 Feb 28;13:1523207. doi: 10.3389/fpubh.2025.1523207. eCollection 2025. Front Public Health. 2025. PMID: 40093727 Free PMC article.

43

Reducing PDK4 level constitutes a pivotal mechanism for glucocorticoids to impede osteoblastic differentiation through the enhancement of ferroptosis in mesenchymal stem cells.

Jiang Y, Ye AH, He WG, Liu L, Gao X, Liu H, Liu WT, Ye FL, He DM, Liao JY, Wang J, He BC. Jiang Y, et al. Stem Cell Res Ther. 2025 Feb 25;16(1):91. doi: 10.1186/s13287-025-04186-9. Stem Cell Res Ther. 2025. PMID: 40001240 Free PMC article.

44

Effects of Denosumab and Bisphosphonates on Glucocorticoid-induced Osteoporosis in Patients with Neuroimmunological Disorders.

Handa H, Uzawa A, Mori M, Yasuda M, Onishi Y, Akamine H, Ogaya E, Niibe Y, Yokota H, Kuwabara S. Handa H, et al. Intern Med. 2025 Feb 15;64(4):543-549. doi: 10.2169/internalmedicine.3954-24. Epub 2024 Jul 11. Intern Med. 2025. PMID: 38987183 Free PMC article.

45

Osteoporosis Among Glucocorticoid-treated Patients with Giant-cell Arteritis: A Population-based Cohort Analysis.

Varda B, Zur AD, Kuntzman Y, Patt YS, Amital H, Cohen AD, Gendelman O. Varda B, et al. Isr Med Assoc J. 2025 Feb;27(2):98-102. Isr Med Assoc J. 2025. PMID: 40170647 Free article.

46

Factors influencing therapeutic efficacy of denosumab against osteoporosis in systemic lupus erythematosus.

Yang J, Park Y, Lee JJ, Kwok SK, Ju JH, Kim WU, Park SH. Yang J, et al. Lupus Sci Med. 2025 Jan 22;12(1):e001438. doi: 10.1136/lupus-2024-001438. Lupus Sci Med. 2025. PMID: 39843360 Free PMC article.

47

Approach to the Pediatric Patient With Glucocorticoid-Induced Osteoporosis.

Ward LM, Bakhamis SA, Koujok K. Ward LM, et al. J Clin Endocrinol Metab. 2025 Jan 21;110(2):572-591. doi: 10.1210/clinem/dgae507. J Clin Endocrinol Metab. 2025. PMID: 39126675 Free PMC article.

48

Investigating the preventive effects of pulsed electromagnetic fields on glucocorticoid-induced osteoporosis in rats.

Ding S, Zhang G, Gao Y, Hou Z, Shao F. Ding S, et al. Sci Rep. 2025 Jan 20;15(1):2535. doi: 10.1038/s41598-025-86594-8. Sci Rep. 2025. PMID: 39833378 Free PMC article.

49

Effect of Zoledronic Acid on the Femoral Bone Morphology and Innervation in Rats with Glucocorticoid-Induced Osteoporosis.

Kostyshyn NM, Tomaszewska E, Muszyński S, Arciszewski MB, Mielnik-Błaszczak M, Kuc D, Dobrowolski P. Kostyshyn NM, et al. Folia Biol (Praha). 2025;71(5-6):193-211. doi: 10.14712/fb2025.0005. Folia Biol (Praha). 2025. PMID: 41739706 Free article.

50

Glucocorticoid receptor polymorphisms and bone mineral density in patients receiving conventional glucocorticoid replacement.

Fichna M, Furman K, Żurawek M, Wrotkowska E, Ruchała M. Fichna M, et al. Endokrynol Pol. 2025;76(5):534-542. doi: 10.5603/ep.106658. Epub 2025 Sep 25. Endokrynol Pol. 2025. PMID: 40995703 Free article.

51

Hormonal influence on osteoporosis.

Rupeć Z, Trubalski M, Zulfiquar Z, Bełżek A, Żerebiec M, Saj N, Kamiński P, Kaczmarski M, Rizvi F, Kłapeć W. Rupeć Z, et al. Wiad Lek. 2025;78(3):531-538. doi: 10.36740/WLek/202332. Wiad Lek. 2025. PMID: 40219878 Free article. Review.

52

Tau is a receptor with low affinity for glucocorticoids and is required for glucocorticoid-induced bone loss.

Fu W, Chen M, Wang K, Chen Y, Cui Y, Xie Y, Lei ZN, Hu W, Sun G, Huang G, He C, Fretz J, Hettinghouse A, Liu R, Cai X, Zhang M, Chen Y, Jiang N, He M, Wiznia DH, Xu H, Chen ZS, Chen L, Tang K, Zhou H, Liu CJ. Fu W, et al. Cell Res. 2025 Jan;35(1):23-44. doi: 10.1038/s41422-024-01016-0. Epub 2025 Jan 2. Cell Res. 2025. PMID: 39743632 Free PMC article.

53

Superiority of denosumab over bisphosphonates in preventing and treating glucocorticoid-induced osteoporosis: a systematic review and meta-analysis with GRADE quality assessment.

Chen CL, Wang JY. Chen CL, et al. Front Endocrinol (Lausanne). 2024 Dec 18;15:1407692. doi: 10.3389/fendo.2024.1407692. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39744180 Free PMC article.

54

The pivotal role of the Hes1/Piezo1 pathway in the pathophysiology of glucocorticoid-induced osteoporosis.

Ochiai N, Etani Y, Noguchi T, Miura T, Kurihara T, Fukuda Y, Hamada H, Uemura K, Takashima K, Tamaki M, Ishibashi T, Ito S, Yamakawa S, Kanamoto T, Okada S, Nakata K, Ebina K. Ochiai N, et al. JCI Insight. 2024 Dec 6;9(23):e179963. doi: 10.1172/jci.insight.179963. JCI Insight. 2024. PMID: 39641269 Free PMC article.

55

Factors influencing the development of osteoporosis in elderly patients with rheumatoid arthritis.

Yang Y, Chen Y, Zhang L, Yang X, Qiao J. Yang Y, et al. Afr Health Sci. 2024 Dec;24(4):308-312. doi: 10.4314/ahs.v24i4.39. Afr Health Sci. 2024. PMID: 40190502 Free PMC article.

56

Rehmannioside A promotes the osteoblastic differentiation of MC3T3-E1 cells via the PI3K/AKT signaling pathway and inhibits glucocorticoid-induced bone loss in vivo.

Huang H, Ji F, Qi G, Cao Y, He X, Wang H, Jiang Z. Huang H, et al. J Pharmacol Sci. 2024 Dec;156(4):247-257. doi: 10.1016/j.jphs.2024.11.001. Epub 2024 Nov 6. J Pharmacol Sci. 2024. PMID: 39608850 Free article.

57

Evaluation of psoriasis patients with long-term topical corticosteroids for their risk of developing adrenal insufficiency, Cushing's syndrome and osteoporosis.

Erdem B, Gonul M, Ozturk Unsal I, Ozdemir Sahingoz S. Erdem B, et al. J Dermatolog Treat. 2024 Dec;35(1):2298880. doi: 10.1080/09546634.2023.2298880. Epub 2023 Dec 29. J Dermatolog Treat. 2024. PMID: 38156462 Free article.

58

Osteoporosis and Rheumatoid Arthritis: A Review of Current Understanding and Practice.

Kirkham-Wilson F, Dennison E. Kirkham-Wilson F, et al. Br J Hosp Med (Lond). 2024 Nov 30;85(11):1-11. doi: 10.12968/hmed.2024.0341. Epub 2024 Nov 13. Br J Hosp Med (Lond). 2024. PMID: 39618224 Free article. Review.

59

Eucommia ulmoides Oliver polysaccharide alleviates glucocorticoid-induced osteoporosis by stimulating bone formation via ERK/BMP-2/SMAD signaling.

Song J, Zhang Y, Jin X, Zhu Y, Li Y, Hu M. Song J, et al. Sci Rep. 2024 Nov 28;14(1):29647. doi: 10.1038/s41598-024-80859-4. Sci Rep. 2024. PMID: 39609585 Free PMC article.

60

Generation of BT-Amide, a Bone-Targeted Pyk2 Inhibitor, Effective via Oral Administration, for the Prevention of Glucocorticoid-Induced Bone Loss.

Wang X, Sato AY, Marino S, Akel N, Boysen G, Basnakian AG, Bellido TM, Li HY. Wang X, et al. J Med Chem. 2024 Nov 28;67(22):20708-20720. doi: 10.1021/acs.jmedchem.4c02539. Epub 2024 Nov 14. J Med Chem. 2024. PMID: 39540576 Free PMC article.

61

Methotrexate inhibits glucocorticoids-induced osteoclastogenesis via activating IFN-γR/STAT1 pathway in the treatment of rheumatoid arthritis.

Teng Y, Yin H, Feng R, Jiang L, Qiu W, Duan X, Wang X, Deng GM. Teng Y, et al. RMD Open. 2024 Nov 7;10(4):e004886. doi: 10.1136/rmdopen-2024-004886. RMD Open. 2024. PMID: 39510764 Free PMC article.

62

Neuroprotective macromolecular methylprednisolone prodrug nanomedicine prevents glucocorticoid-induced muscle atrophy and osteoporosis in a rat model of spinal cord injury.

Qin Y, Zhao W, Jia Z, Bauman WA, Peng Y, Guo XE, Chen Z, He Z, Cardozo CP, Wang D, Qin W. Qin Y, et al. Nanomedicine. 2024 Nov;62:102773. doi: 10.1016/j.nano.2024.102773. Epub 2024 Jul 2. Nanomedicine. 2024. PMID: 38960364 Free PMC article.

63

Real-world treatment patterns in patients with systemic lupus erythematosus: associations with comorbidities and damage.

Eviatar T, Yahalom R, Livnat I, Elboim M, Elkayam O, Chodick G, Rosenberg V, Paran D. Eviatar T, et al. Lupus Sci Med. 2024 Sep 24;11(2):e001266. doi: 10.1136/lupus-2024-001266. Lupus Sci Med. 2024. PMID: 39317452 Free PMC article.

64

Comparative performance analysis of large language models: ChatGPT-3.5, ChatGPT-4 and Google Gemini in glucocorticoid-induced osteoporosis.

Tong L, Zhang C, Liu R, Yang J, Sun Z. Tong L, et al. J Orthop Surg Res. 2024 Sep 18;19(1):574. doi: 10.1186/s13018-024-04996-2. J Orthop Surg Res. 2024. PMID: 39289734 Free PMC article.

65

Excessive glucocorticoids combined with RANKL promote the differentiation of bone marrow macrophages (BMM) into osteoclasts and accelerate the progression of osteoporosis by activating the SYK/SHP2/NF-κB signaling pathway.

Dong H, Liu X, Duan J, Zhang J, Liu H, Shen T. Dong H, et al. Aging (Albany NY). 2024 Aug 27;16(17):12263-12276. doi: 10.18632/aging.206084. Epub 2024 Aug 27. Aging (Albany NY). 2024. PMID: 39197167 Free PMC article.

66

Loss of BACH1 improves osteogenic differentiation in glucocorticoid-induced hBMSCs through restoring autophagy.

Xiao S, Li G, Tan M, Liu W, Li W. Xiao S, et al. BMC Musculoskelet Disord. 2024 Aug 24;25(1):665. doi: 10.1186/s12891-024-07761-y. BMC Musculoskelet Disord. 2024. PMID: 39182017 Free PMC article.

67

Dual-Energy X-Ray Absorptiometry Scan Utilization and Skeletal Fragility Among Non-Infectious Uveitis Patients Exposed to Oral Glucocorticoids.

Butler NJ, Cohen D, Yu Y, Kempen JH, Sobrin L, VanderBeek BL. Butler NJ, et al. Ocul Immunol Inflamm. 2024 Aug;32(6):994-1002. doi: 10.1080/09273948.2023.2182793. Epub 2023 Mar 9. Ocul Immunol Inflamm. 2024. PMID: 36893445 Free PMC article.

68

Functions of Epimedin C in a zebrafish model of glucocorticoid-induced osteoporosis.

Zhou X, Lian K, Jia J, Zhao X, Duan P, Huang J, Shi Y. Zhou X, et al. J Cell Mol Med. 2024 Jul;28(14):e18569. doi: 10.1111/jcmm.18569. J Cell Mol Med. 2024. PMID: 39072972 Free PMC article.

69

Protein kinase G2 activation restores Wnt signaling and bone mass in glucocorticoid-induced osteoporosis in mice.

Pal China S, Kalyanaraman H, Zhuang S, Cabriales JA, Sah RL, Pilz RB. Pal China S, et al. JCI Insight. 2024 Jun 17;9(14):e175089. doi: 10.1172/jci.insight.175089. JCI Insight. 2024. PMID: 38885330 Free PMC article.

70

Mitochondria from osteolineage cells regulate myeloid cell-mediated bone resorption.

Ding P, Gao C, Zhou J, Mei J, Li G, Liu D, Li H, Liao P, Yao M, Wang B, Lu Y, Peng X, Jiang C, Yin J, Huang Y, Zheng M, Gao Y, Zhang C, Gao J. Ding P, et al. Nat Commun. 2024 Jun 14;15(1):5094. doi: 10.1038/s41467-024-49159-3. Nat Commun. 2024. PMID: 38877020 Free PMC article.

71

Combined application of mesenchymal stem cells and different glucocorticoid dosing alleviates osteoporosis in SLE murine models.

Ding S, Ren T, Song S, Peng C, Liu C, Wu J, Chang X. Ding S, et al. Immun Inflamm Dis. 2024 Jun;12(6):e1319. doi: 10.1002/iid3.1319. Immun Inflamm Dis. 2024. PMID: 38888448 Free PMC article.

72

Pharmacist-initiated interventions to test quantitative bone mineral density and prescribe osteoporosis medications to prevent steroid-induced osteoporosis.

Hirose T, Mori K, Kimura M, Yamashita S, Hayashi H, Usami E, Tanase T. Hirose T, et al. Pharmazie. 2024 Jun 1;79(6):124-128. doi: 10.1691/ph.2024.4510. Pharmazie. 2024. PMID: 38877679 Free article.

73

Association of serum sclerostin levels with marrow adiposity in postmenopausal women with glucocorticoid-induced osteoporosis.

Li W, Wang W, Zhang M, Chen Q, Li F, Li S. Li W, et al. BMC Endocr Disord. 2024 Apr 28;24(1):55. doi: 10.1186/s12902-024-01591-8. BMC Endocr Disord. 2024. PMID: 38679740 Free PMC article.

74

Patient preference, efficacy, and compliance with zoledronic acid for glucocorticoid-induced osteoporosis in patients with autoimmune diseases.

Kim JW, Jung JY, Kim HA, Son H, Suh CH. Kim JW, et al. Postgrad Med J. 2024 Apr 22;100(1183):334-341. doi: 10.1093/postmj/qgae003. Postgrad Med J. 2024. PMID: 38297995 Free article.

75

[Vertebral fractures combined with prolonged activated partial prothrombin time: A case report].

Bai X, He J, Lu S, Li C, Wang Y, Xiong J. Bai X, et al. Beijing Da Xue Xue Bao Yi Xue Ban. 2024 Apr 18;56(2):371-374. doi: 10.19723/j.issn.1671-167X.2024.02.028. Beijing Da Xue Xue Bao Yi Xue Ban. 2024. PMID: 38595261 Free PMC article. Chinese.

76

Gli1⁺ Progenitors Mediate Glucocorticoid-Induced Osteoporosis In Vivo.

Yang P, Shen F, You C, Lou F, Shi Y. Yang P, et al. Int J Mol Sci. 2024 Apr 16;25(8):4371. doi: 10.3390/ijms25084371. Int J Mol Sci. 2024. PMID: 38673956 Free PMC article.

77

Guidelines for the prevention and treatment of glucocorticoid-induced osteoporosis in pediatrics.

Brunetto O, Cassinelli HR, Espada G, Viterbo GL, Meiorin SM, Ahumada MF, Brenzoni L, Maher MC, Chavero I, Ramírez Stieben LA, Brance ML. Brunetto O, et al. Arch Argent Pediatr. 2024 Apr 1;122(2):e202202948. doi: 10.5546/aap.2022-02948.eng. Epub 2023 Jul 6. Arch Argent Pediatr. 2024. PMID: 37382585 Free article. English, Spanish.

78

Potential therapeutic role of spermine via Rac1 in osteoporosis: Insights from zebrafish and mice.

Jiang RX, Hu N, Deng YW, Hu LW, Gu H, Luo N, Wen J, Jiang XQ. Jiang RX, et al. Zool Res. 2024 Mar 18;45(2):367-380. doi: 10.24272/j.issn.2095-8137.2023.371. Zool Res. 2024. PMID: 38485506 Free PMC article.

79

The 2023 Guidelines for the management and treatment of glucocorticoid-induced osteoporosis.

Tanaka Y, Soen S, Hirata S, Okada Y, Fujiwara S, Tanaka I, Kitajima Y, Kubota T, Ebina K, Takashi Y, Inoue R, Yamauchi M, Okubo N, Ueno M, Ohata Y, Ito N, Ozono K, Nakayama H, Terauchi M, Tanaka S, Fukumoto S. Tanaka Y, et al. J Bone Miner Metab. 2024 Mar;42(2):143-154. doi: 10.1007/s00774-024-01502-w. Epub 2024 Mar 28. J Bone Miner Metab. 2024. PMID: 38538869 Free PMC article.

80

Analyzing the factors associated with efficacy among teriparatide treatment in postmenopausal women with osteoporosis.

Kong M, Gao C, Luan X, Fan C, Hao M, Jin C, Zhao J, Li H, Zhao J, Luan J, Lin Y, Li Q. Kong M, et al. BMC Musculoskelet Disord. 2024 Feb 3;25(1):109. doi: 10.1186/s12891-024-07227-1. BMC Musculoskelet Disord. 2024. PMID: 38310278 Free PMC article.

81

Response to Letter to the Editor: Thresholds based on bone mineral density for therapeutic decision-making in postmenopausal women and men older than 50 years old under glucocorticoid therapy.

Brance ML, Larroudé MS, Somma LF, Ramirez Stieben LA, Brun LR. Brance ML, et al. Reumatol Clin (Engl Ed). 2024 Feb;20(2):114-115. doi: 10.1016/j.reumae.2023.09.005. Reumatol Clin (Engl Ed). 2024. PMID: 38395495 Free article. No abstract available.

82

Comments about treatment of glucocorticoid-induced osteoporosis.

Messina OD. Messina OD. Reumatol Clin (Engl Ed). 2024 Feb;20(2):113. doi: 10.1016/j.reumae.2023.07.006. Epub 2024 Feb 7. Reumatol Clin (Engl Ed). 2024. PMID: 38331664 Free article. No abstract available.

83

Gut microbial community and fecal metabolomic signatures in different types of osteoporosis animal models.

Qiao X, Li X, Wang Z, Feng Y, Wei X, Li L, Pan Y, Zhang K, Zhou R, Yan L, Li P, Xu C, Lv Z, Tian Z. Qiao X, et al. Aging (Albany NY). 2024 Jan 26;16(2):1192-1217. doi: 10.18632/aging.205396. Epub 2024 Jan 26. Aging (Albany NY). 2024. PMID: 38284894 Free PMC article.

84

Bisphosphonates in Glucocorticoid-Treated Patients With Duchenne Muscular Dystrophy: A Systematic Review and Grading of the Evidence.

Landfeldt E, Phung K, Zaman F, Åström E, Abner S, Lochmüller H, Sejersen T, Ward LM. Landfeldt E, et al. Neurology. 2024 Jan 23;102(2):e207948. doi: 10.1212/WNL.0000000000207948. Epub 2023 Dec 18. Neurology. 2024. PMID: 38165327 Free PMC article.

85

Lactobacillus plantarum attenuates glucocorticoid-induced osteoporosis by altering the composition of rat gut microbiota and serum metabolic profile.

Li S, Han X, Liu N, Chang J, Liu G, Hu S. Li S, et al. Front Immunol. 2024 Jan 9;14:1285442. doi: 10.3389/fimmu.2023.1285442. eCollection 2023. Front Immunol. 2024. PMID: 38264658 Free PMC article.

86

Therapeutic Effects of Mechanical Stress-Induced C2C12-Derived Exosomes on Glucocorticoid-Induced Osteoporosis Through miR-92a-3p/PTEN/AKT Signaling Pathway.

Xu N, Cui G, Zhao S, Li Y, Liu Q, Liu X, Zhao C, Feng R, Kuang M, Han S. Xu N, et al. Int J Nanomedicine. 2023 Dec 12;18:7583-7603. doi: 10.2147/IJN.S435301. eCollection 2023. Int J Nanomedicine. 2023. PMID: 38106447 Free PMC article.

87

Catalpol ameliorates dexamethasone-induced osteoporosis by promoting osteogenic differentiation of bone marrow mesenchymal stem cells via the activation of PKD1 promoter.

Xu L, Xu G, Sun N, Yao J, Wang C, Zhang W, Tian K, Liu M, Sun H. Xu L, et al. J Pharmacol Sci. 2023 Dec;153(4):221-231. doi: 10.1016/j.jphs.2023.10.002. Epub 2023 Oct 17. J Pharmacol Sci. 2023. PMID: 37973220 Free article.

88

2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, Caplan L, Gore S, Grossman J, Hansen KE, Lane NE, Ma NS, Magrey M, McAlindon T, Robinson AB, Saha S, Womack C, Abdulhadi B, Charles JF, Cheah JTL, Chou S, Goyal I, Haseltine K, Jackson L, Mirza R, Moledina I, Punni E, Rinden T, Turgunbaev M, Wysham K, Turner AS, Uhl S. Humphrey MB, et al. Arthritis Care Res (Hoboken). 2023 Dec;75(12):2405-2419. doi: 10.1002/acr.25240. Epub 2023 Oct 26. Arthritis Care Res (Hoboken). 2023. PMID: 37884467 Free article.

89

2022 American College of Rheumatology Guideline for the Prevention and Treatment of Glucocorticoid-Induced Osteoporosis.

Humphrey MB, Russell L, Danila MI, Fink HA, Guyatt G, Cannon M, Caplan L, Gore S, Grossman J, Hansen KE, Lane NE, Ma NS, Magrey M, McAlindon T, Robinson AB, Saha S, Womack C, Abdulhadi B, Charles JF, Cheah JTL, Chou S, Goyal I, Haseltine K, Jackson L, Mirza R, Moledina I, Punni E, Rinden T, Turgunbaev M, Wysham K, Turner AS, Uhl S. Humphrey MB, et al. Arthritis Rheumatol. 2023 Dec;75(12):2088-2102. doi: 10.1002/art.42646. Epub 2023 Oct 16. Arthritis Rheumatol. 2023. PMID: 37845798 Free article.

90

Mineral and bone disorder after kidney transplantation: a single-center cohort study.

Sun L, Wang Z, Zheng M, Hang Z, Liu J, Gao X, Gui Z, Feng D, Zhang D, Han Q, Fei S, Chen H, Tao J, Han Z, Ju X, Gu M, Tan R. Sun L, et al. Ren Fail. 2023 Dec;45(1):2210231. doi: 10.1080/0886022X.2023.2210231. Ren Fail. 2023. PMID: 37183797 Free PMC article.

91

Morroniside ameliorates glucocorticoid-induced osteoporosis and promotes osteoblastogenesis by interacting with sodium-glucose cotransporter 2.

Yang HZ, Dong R, Jia Y, Li Y, Luo G, Li T, Long Y, Liang S, Li S, Jin X, Sun T. Yang HZ, et al. Pharm Biol. 2023 Dec;61(1):416-426. doi: 10.1080/13880209.2023.2173787. Pharm Biol. 2023. PMID: 36786302 Free PMC article.

92

Acteoside Derived from Cistanche Improves Glucocorticoid-Induced Osteoporosis by Activating PI3K/AKT/mTOR Pathway.

Li S, Cui Y, Li M, Zhang W, Sun X, Xin Z, Li J. Li S, et al. J Invest Surg. 2023 Dec;36(1):2154578. doi: 10.1080/08941939.2022.2154578. J Invest Surg. 2023. PMID: 36521840 Free article.

93

Association between dietary selenium intake and the prevalence of osteoporosis and its role in the treatment of glucocorticoid-induced osteoporosis.

Luo Y, Xiang Y, Lu B, Tan X, Li Y, Mao H, Huang Q. Luo Y, et al. J Orthop Surg Res. 2023 Nov 15;18(1):867. doi: 10.1186/s13018-023-04276-5. J Orthop Surg Res. 2023. PMID: 37968755 Free PMC article.

94

Disturbed bone marrow adiposity in patients with Cushing's syndrome and glucocorticoid- and postmenopausal- induced osteoporosis.

Sørensen NN, Andreasen CM, Jensen PR, Hauge EM, Bollerslev J, Delaissé JM, Kassem M, Jafari A, Diaz-delCastillo M, Andersen TL. Sørensen NN, et al. Front Endocrinol (Lausanne). 2023 Oct 10;14:1232574. doi: 10.3389/fendo.2023.1232574. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37881495 Free PMC article.

95

Pharmacological Interventions for Glucocorticoid-Induced Osteoporosis: An Umbrella Review.

Liang H, Zhao J, Tian T. Liang H, et al. Horm Metab Res. 2023 Aug;55(8):511-519. doi: 10.1055/a-2112-1596. Epub 2023 Jun 19. Horm Metab Res. 2023. PMID: 37336498 Free PMC article.

96

11β-Hydroxysteroid Dehydrogenase Type 1 Facilitates Osteoporosis by Turning on Osteoclastogenesis through Hippo Signaling.

Li H, Hu S, Wu R, Zhou H, Zhang K, Li K, Lin W, Shi Q, Chen H, Lv S. Li H, et al. Int J Biol Sci. 2023 Jul 15;19(11):3628-3639. doi: 10.7150/ijbs.82933. eCollection 2023. Int J Biol Sci. 2023. PMID: 37496992 Free PMC article.

97

Bisphosphonate use for glucocorticoid-induced osteoporosis in older patients with immune thrombocytopenia: a clinical perspective.

Yamasaki S. Yamasaki S. Ann Hematol. 2023 Jul;102(7):1645-1656. doi: 10.1007/s00277-023-05266-7. Epub 2023 May 12. Ann Hematol. 2023. PMID: 37171596 Free PMC article. Review.

98

Effects of genistein aglycone in glucocorticoid induced osteoporosis: A randomized clinical trial in comparison with alendronate.

Squadrito F, Imbalzano E, Rottura M, Arcoraci V, Pallio G, Catalano A, Atteritano M, Irrera N, Mannino F, Squadrito G, Vaccaro M, Irrera P, Pirrotta I, Bitto A. Squadrito F, et al. Biomed Pharmacother. 2023 Jul;163:114821. doi: 10.1016/j.biopha.2023.114821. Epub 2023 May 9. Biomed Pharmacother. 2023. PMID: 37167726 Free article. Clinical Trial.

99

Galangin mitigates glucocorticoid-induced osteoporosis by activating autophagy of BMSCs via triggering the PKA/CREB signaling pathway.

Zeng C, Wang S, Gu H, Chen F, Wang Z, Li J, Xie Z, Feng P, Shen H, Wu Y. Zeng C, et al. Acta Biochim Biophys Sin (Shanghai). 2023 Jun 26;55(8):1275-1287. doi: 10.3724/abbs.2023063. Acta Biochim Biophys Sin (Shanghai). 2023. PMID: 37365870 Free PMC article.

100

Clinical efficacy of denosumab, teriparatide, and oral bisphosphonates in the prevention of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis.

Yuan C, Liang Y, Zhu K, Xie W. Yuan C, et al. J Orthop Surg Res. 2023 Jun 22;18(1):447. doi: 10.1186/s13018-023-03920-4. J Orthop Surg Res. 2023. PMID: 37349750 Free PMC article.

101

Metabolomics analysis of the potential mechanism of Yi-Guan-Jian decoction to reverse bone loss in glucocorticoid-induced osteoporosis.

Yin M, Zhou D, Jia F, Su X, Li X, Sun R, Li J. Yin M, et al. J Orthop Surg Res. 2023 Jun 5;18(1):409. doi: 10.1186/s13018-023-03778-6. J Orthop Surg Res. 2023. PMID: 37277810 Free PMC article.

102

Screening for osteoporosis in people with MS: A new risk score.

Zinganell A, Hegen H, Walde J, Bauer A, Berek K, Barket R, Auer M, Bsteh G, Donnemiller E, Egger A, Grams A, Griesmacher A, Kroiss AS, Rettenwander F, Tschallener M, Tschoner A, Berger T, Deisenhammer F, Di Pauli F. Zinganell A, et al. Mult Scler Relat Disord. 2023 Jun;74:104726. doi: 10.1016/j.msard.2023.104726. Epub 2023 Apr 17. Mult Scler Relat Disord. 2023. PMID: 37098303 Free article.

103

Threshold based on bone mineral density for therapeutic decision-making in postmenopausal women and men over 50 years old under glucocorticoid therapy.

Brance ML, Larroudé MS, Somma LF, Giacoia E, Diehl M, Galich AM, Ramirez Stieben LA, Maher MC, De La Vega M, Ringer A, Brun LR. Brance ML, et al. Reumatol Clin (Engl Ed). 2023 May;19(5):279-284. doi: 10.1016/j.reumae.2022.10.002. Reumatol Clin (Engl Ed). 2023. PMID: 37147063 Free article.

104

Diosmin mitigates dexamethasone-induced osteoporosis in vivo: Role of Runx2, RANKL/OPG, and oxidative stress.

Arafa EA, Elgendy NO, Elhemely MA, Abdelaleem EA, Mohamed WR. Arafa EA, et al. Biomed Pharmacother. 2023 May;161:114461. doi: 10.1016/j.biopha.2023.114461. Epub 2023 Mar 6. Biomed Pharmacother. 2023. PMID: 36889109 Free article.

105

Effect of Bisphosphonate and Active Vitamin D Analog on Glucocorticoid-induced Osteoporosis in Patients with IgA Nephropathy: A Retrospective Observational Study.

Takiguchi R, Nishi S, Goto S, Fujii H. Takiguchi R, et al. Kobe J Med Sci. 2023 Apr 17;69(1):E9-E15. Kobe J Med Sci. 2023. PMID: 37088694 Free PMC article.

106

Glucocorticoid induced bone disorders in children: Research progress in treatment mechanisms.

Hua J, Huang J, Li G, Lin S, Cui L. Hua J, et al. Front Endocrinol (Lausanne). 2023 Apr 4;14:1119427. doi: 10.3389/fendo.2023.1119427. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37082116 Free PMC article. Review.

107

Senescence of bone marrow fat cells: A new clue for glucocorticoid-induced bone deterioration.

Tong L, Chen D. Tong L, et al. Cell Metab. 2023 Apr 4;35(4):551-553. doi: 10.1016/j.cmet.2023.03.009. Cell Metab. 2023. PMID: 37019078 Free article.

108

Pathogenic mechanisms of glucocorticoid-induced osteoporosis.

Chen M, Fu W, Xu H, Liu CJ. Chen M, et al. Cytokine Growth Factor Rev. 2023 Apr;70:54-66. doi: 10.1016/j.cytogfr.2023.03.002. Epub 2023 Mar 5. Cytokine Growth Factor Rev. 2023. PMID: 36906448 Free PMC article. Review.

109

Comparison of Bisphosphonates Versus Teriparatide in Therapy of the Glucocorticoid-Induced Osteoporosis (GIOP): A Meta-Analysis of Randomized Controlled Trials.

Dong B, Zhou Y, Wang J, Li C, Fu Z, Huang Y, Wang Y, Xu L. Dong B, et al. Horm Metab Res. 2023 Apr;55(4):236-244. doi: 10.1055/a-2015-1747. Epub 2023 Jan 18. Horm Metab Res. 2023. PMID: 36652960 Free article.

110

Potential Targets and Mechanisms of Jiedu Quyu Ziyin Decoction for Treating SLE-GIOP: Based on Network Pharmacology and Molecular Docking.

Li J, Chang RY, Chen LF, Qian SH, Wang RY, Lan JL, Huang L, Ding XH. Li J, et al. J Immunol Res. 2023 Mar 28;2023:8942415. doi: 10.1155/2023/8942415. eCollection 2023. J Immunol Res. 2023. PMID: 37026113 Free PMC article.

111

Hormone-Related and Drug-Induced Osteoporosis: A Cellular and Molecular Overview.

Wang LT, Chen LR, Chen KH. Wang LT, et al. Int J Mol Sci. 2023 Mar 18;24(6):5814. doi: 10.3390/ijms24065814. Int J Mol Sci. 2023. PMID: 36982891 Free PMC article. Review.

112

Biological effect of bone marrow mesenchymal stem cell- derived extracellular vesicles on the structure of alveolar bone in rats with glucocorticoid-induced osteoporosis.

Sedik AS, Kawana KY, Koura AS, Mehanna RA. Sedik AS, et al. BMC Musculoskelet Disord. 2023 Mar 17;24(1):205. doi: 10.1186/s12891-023-06276-2. BMC Musculoskelet Disord. 2023. PMID: 36932362 Free PMC article.

113

Efficacy of Bushen Jiangu therapy in the treatment of glucocorticoid-induced osteoporosis: A systematic review and meta-analysis of randomized controlled trials.

Yin X, Zhao S, Xiang N, Chen J, Xu J, Zhang Y. Yin X, et al. Medicine (Baltimore). 2023 Mar 17;102(11):e33278. doi: 10.1097/MD.0000000000033278. Medicine (Baltimore). 2023. PMID: 36930100 Free PMC article.

114

Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis.

Compston JE. Compston JE. Eur J Endocrinol. 2023 Mar 2;188(3):R46-R55. doi: 10.1093/ejendo/lvad029. Eur J Endocrinol. 2023. PMID: 36880157 Free article.

115

Linking the relation between gut microbiota and glucocorticoid-induced osteoporosis.

Zhou RX, Zhang YW, Cao MM, Liu CH, Rui YF, Li YJ. Zhou RX, et al. J Bone Miner Metab. 2023 Mar;41(2):145-162. doi: 10.1007/s00774-023-01415-0. Epub 2023 Mar 13. J Bone Miner Metab. 2023. PMID: 36912997 Free PMC article. Review.

116

Bad to the bones: prescribing of drugs for the prevention and treatment of osteoporosis in patients on chronic glucocorticoids.

Billups SJ, Thai VK, Denkins J, Dettman IC, Rothman MS. Billups SJ, et al. Arch Osteoporos. 2023 Mar 1;18(1):38. doi: 10.1007/s11657-023-01222-0. Arch Osteoporos. 2023. PMID: 36856881 Free PMC article.

117

Allolobophora caliginosa coelomic fluid and extract alleviate glucocorticoid-induced osteoporosis in mice by suppressing oxidative stress and regulating osteoblastic/osteoclastic-related markers.

Abdelfattah MA, Mohamed AS, Ibrahim SA, Fahmy SR. Abdelfattah MA, et al. Sci Rep. 2023 Feb 6;13(1):2090. doi: 10.1038/s41598-023-29070-5. Sci Rep. 2023. PMID: 36746995 Free PMC article.

118

Exosomes from Adipose-Derived Stem Cells Alleviate Dexamethasone-Induced Bone Loss by Regulating the Nrf2/HO-1 Axis.

Yao XW, Liu ZY, Ma NF, Jiang WK, Zhou Z, Chen B, Guan WG, Yan JJ, Yang M. Yao XW, et al. Oxid Med Cell Longev. 2023 Feb 1;2023:3602962. doi: 10.1155/2023/3602962. eCollection 2023. Oxid Med Cell Longev. 2023. PMID: 36778207 Free PMC article.

119

Effectiveness and prognostic factors of different minimally invasive surgeries for vertebral compression fractures.

Wang W, Liu Y, Wan H, Zeng L, Peng Z, Yang D, Tian K. Wang W, et al. BMC Musculoskelet Disord. 2023 Jan 6;24(1):11. doi: 10.1186/s12891-022-06125-8. BMC Musculoskelet Disord. 2023. PMID: 36609293 Free PMC article.

120

Overexpression of Wnt7b antagonizes the inhibitory effect of dexamethasone on osteoblastogenesis of ST2 cells.

Gu Y, Gao Y, Yang Z, Ni J, He G. Gu Y, et al. Endokrynol Pol. 2023;74(1):83-88. doi: 10.5603/EP.a2022.0035. Epub 2023 Jan 27. Endokrynol Pol. 2023. PMID: 36704983 Free article.

121

Metabolic bone health considerations in giant cell arteritis and polymyalgia rheumatica.

Low C, Conway R. Low C, et al. Womens Health (Lond). 2023 Jan-Dec;19:17455057221147385. doi: 10.1177/17455057221147385. Womens Health (Lond). 2023. PMID: 36627860 Free PMC article. Review.

122

A clinical herbal prescription Gu-Shu-Kang capsule exerted beneficial effects on the musculoskeletal system of dexamethasone-treated mice by acting on tissue IGF-1 signalling pathway.

Li XL, Wang L, He MC, Li WX, Zhang JL, Fu YF, Zhang Y. Li XL, et al. Pharm Biol. 2022 Dec;60(1):2098-2109. doi: 10.1080/13880209.2022.2132029. Pharm Biol. 2022. PMID: 36269032 Free PMC article.

123

Dexamethasone promotes osteoblast apoptosis through the Chk2/p53 signaling pathway.

Zhu J, Zhao T, Zhu L, Yin C, Liu Y, Fang J, Liang H, Zhen Y. Zhu J, et al. Adv Clin Exp Med. 2022 Dec;31(12):1365-1374. doi: 10.17219/acem/152150. Adv Clin Exp Med. 2022. PMID: 36083253 Free article.

124

Prevalence of osteoporosis and osteopenia in elderly patients scheduled for total knee arthroplasty.

Delsmann MM, Schmidt C, Mühlenfeld M, Jandl NM, Boese CK, Beil FT, Rolvien T, Ries C. Delsmann MM, et al. Arch Orthop Trauma Surg. 2022 Dec;142(12):3957-3964. doi: 10.1007/s00402-021-04297-x. Epub 2021 Dec 17. Arch Orthop Trauma Surg. 2022. PMID: 34919186 Free PMC article.

125

Comparison of denosumab and oral bisphosphonates for the treatment of glucocorticoid-induced osteoporosis: a systematic review and meta-analysis.

Jiang L, Dong J, Wei J, Liu L. Jiang L, et al. BMC Musculoskelet Disord. 2022 Nov 29;23(1):1027. doi: 10.1186/s12891-022-05997-0. BMC Musculoskelet Disord. 2022. PMID: 36447169 Free PMC article.

126

ED-71 Prevents Glucocorticoid-Induced Osteoporosis by Regulating Osteoblast Differentiation via Notch and Wnt/β-Catenin Pathways.

Rong X, Kou Y, Zhang Y, Yang P, Tang R, Liu H, Li M. Rong X, et al. Drug Des Devel Ther. 2022 Nov 15;16:3929-3946. doi: 10.2147/DDDT.S377001. eCollection 2022. Drug Des Devel Ther. 2022. PMID: 36411860 Free PMC article.

127

Geniposide ameliorates glucocorticoid-induced osteoblast apoptosis by activating autophagy.

Huang J, Ye Y, Xiao Y, Ren Q, Zhou Q, Zhong M, Jiao L, Wu L. Huang J, et al. Biomed Pharmacother. 2022 Nov;155:113829. doi: 10.1016/j.biopha.2022.113829. Epub 2022 Oct 7. Biomed Pharmacother. 2022. PMID: 36271582 Free article.

128

Bone-targeting delivery of platelet lysate exosomes ameliorates glucocorticoid-induced osteoporosis by enhancing bone-vessel coupling.

Zheng G, Ma HW, Xiang GH, He GL, Cai HC, Dai ZH, Chen YL, Lin Y, Xu HZ, Ni WF, Xu C, Liu HX, Wang XY. Zheng G, et al. J Nanobiotechnology. 2022 Oct 31;20(1):220. doi: 10.1186/s12951-022-01400-1. J Nanobiotechnology. 2022. PMID: 36310171 Free PMC article.

129

The Nutraceutical Genistein-Lycopene Combination Improves Bone Damage Induced by Glucocorticoids by Stimulating the Osteoblast Formation Process.

Mannino F, D'Angelo T, Pallio G, Ieni A, Pirrotta I, Giorgi DA, Scarfone A, Mazziotti S, Booz C, Bitto A, Squadrito F, Irrera N. Mannino F, et al. Nutrients. 2022 Oct 14;14(20):4296. doi: 10.3390/nu14204296. Nutrients. 2022. PMID: 36296984 Free PMC article.

130

Risk factors of transport gap bending deformity in the treatment of critical-size bone defect after bone transport.

Abula A, Cheng E, Abulaiti A, Liu K, Liu Y, Ren P. Abula A, et al. BMC Musculoskelet Disord. 2022 Oct 8;23(1):900. doi: 10.1186/s12891-022-05852-2. BMC Musculoskelet Disord. 2022. PMID: 36209097 Free PMC article.

131

Electronic health record data use in the assessment of quality indicators for glucocorticoid osteoporosis screening in systemic lupus erythematosus.

Ko D, Forrest N, Mai Q, Pawlowski A, Balsley K, Chung A, Ramsey-Goldman R, Walunas TL. Ko D, et al. Lupus. 2022 Oct;31(12):1516-1522. doi: 10.1177/09612033221116726. Epub 2022 Jul 20. Lupus. 2022. PMID: 35861184 Free PMC article.

132

Protective Role of β-Sitosterol in Glucocorticoid-Induced Osteoporosis in Rats Via the RANKL/OPG Pathway.

Wang T, Li S, Yi C, Wang X, Han X. Wang T, et al. Altern Ther Health Med. 2022 Oct;28(7):18-25. Altern Ther Health Med. 2022. PMID: 35648689 Free article.

133

Comparative effectiveness of bisphosphonate treatments for the prevention of re-fracture in glucocorticoid-induced osteoporosis: protocol for a systematic review and meta-analysis.

Chu H, Jang BH, Kim G, Bae S, Lee H, Nam S, Ahn J. Chu H, et al. BMJ Open. 2022 Sep 26;12(9):e062537. doi: 10.1136/bmjopen-2022-062537. BMJ Open. 2022. PMID: 36167395 Free PMC article.

134

Antiresorptive treatments for corticosteroid-induced osteoporosis: a Bayesian network meta-analysis.

Migliorini F, Colarossi G, Eschweiler J, Oliva F, Driessen A, Maffulli N. Migliorini F, et al. Br Med Bull. 2022 Sep 22;143(1):46-56. doi: 10.1093/bmb/ldac017. Br Med Bull. 2022. PMID: 35641234 Free PMC article.

135

Tocotrienol as a Protecting Agent against Glucocorticoid-Induced Osteoporosis: A Mini Review of Potential Mechanisms.

Ekeuku SO, Mohd Ramli ES, Abdullah Sani N, Abd Ghafar N, Soelaiman IN, Chin KY. Ekeuku SO, et al. Molecules. 2022 Sep 9;27(18):5862. doi: 10.3390/molecules27185862. Molecules. 2022. PMID: 36144598 Free PMC article. Review.

136

Modified Qing' e Pills exerts anti-osteoporosis effects and prevents bone loss by enhancing type H blood vessel formation.

Lu J, Hu D, Ma C, Xu X, Shen L, Rong J, Zhao J, Shuai B. Lu J, et al. Front Endocrinol (Lausanne). 2022 Sep 6;13:998971. doi: 10.3389/fendo.2022.998971. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36147560 Free PMC article.

137

Effectiveness of a computerized clinical decision support system for prevention of glucocorticoid-induced osteoporosis.

Morikawa T, Sakuma M, Nakamura T, Sonoyama T, Matsumoto C, Takeuchi J, Ohta Y, Kosaka S, Morimoto T. Morikawa T, et al. Sci Rep. 2022 Sep 2;12(1):14967. doi: 10.1038/s41598-022-19079-7. Sci Rep. 2022. PMID: 36056121 Free PMC article.

138

Antiosteoporosis and bone protective effect of dieckol against glucocorticoid-induced osteoporosis in rats.

Wang H, Yang L, Chao J. Wang H, et al. Front Endocrinol (Lausanne). 2022 Aug 19;13:932488. doi: 10.3389/fendo.2022.932488. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36060953 Free PMC article.

139

Editorial: Glucocorticoid and bone: Friend or foe.

Baschant U, Hauser B, Winter EM. Baschant U, et al. Front Endocrinol (Lausanne). 2022 Aug 11;13:995124. doi: 10.3389/fendo.2022.995124. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 36034450 Free PMC article. No abstract available.

140

A bibliometric and visualization analysis of glucocorticoid-induced osteoporosis research from 2012 to 2021.

Jiang B, Feng C, Li C, Tu C, Li Z. Jiang B, et al. Front Endocrinol (Lausanne). 2022 Aug 5;13:961471. doi: 10.3389/fendo.2022.961471. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35992120 Free PMC article.

141

l-Carnitine ameliorates the osteoporotic changes and protects against simvastatin induced myotoxicity and hepatotoxicity in glucocorticoid-induced osteoporosis in rats.

Ahmed SA, Abd El Reheem MH, Elbahy DA. Ahmed SA, et al. Biomed Pharmacother. 2022 Aug;152:113221. doi: 10.1016/j.biopha.2022.113221. Epub 2022 Jun 4. Biomed Pharmacother. 2022. PMID: 35671582 Free article.

142

Total Flavonoids of Drynariae Rhizoma Improve Glucocorticoid-Induced Osteoporosis of Rats: UHPLC-MS-Based Qualitative Analysis, Network Pharmacology Strategy and Pharmacodynamic Validation.

Zhang F, Li Q, Wu J, Ruan H, Sun C, Zhu J, Song Q, Wei X, Shi Y, Zhu L. Zhang F, et al. Front Endocrinol (Lausanne). 2022 Jun 30;13:920931. doi: 10.3389/fendo.2022.920931. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35846330 Free PMC article.

143

Prevention and Treatment of Glucocorticoid-Induced Osteoporosis in Adults: Consensus Recommendations From the Belgian Bone Club.

Laurent MR, Goemaere S, Verroken C, Bergmann P, Body JJ, Bruyère O, Cavalier E, Rozenberg S, Lapauw B, Gielen E. Laurent MR, et al. Front Endocrinol (Lausanne). 2022 Jun 9;13:908727. doi: 10.3389/fendo.2022.908727. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35757436 Free PMC article. Review.

144

Histological and histomorphometric aspects of continual intermittent parathyroid hormone administration on osseointegration in osteoporosis rabbit model.

Oki Y, Doi K, Kobatake R, Makihara Y, Morita K, Kubo T, Tsuga K. Oki Y, et al. PLoS One. 2022 Jun 8;17(6):e0269040. doi: 10.1371/journal.pone.0269040. eCollection 2022. PLoS One. 2022. PMID: 35675357 Free PMC article.

145

Glucocorticoid-induced expansion of classical monocytes contributes to bone loss.

Liu P, Gao Y, Luo P, Yu H, Guo S, Liu F, Gao J, Xu J, Wang S, Zhang C. Liu P, et al. Exp Mol Med. 2022 Jun;54(6):765-776. doi: 10.1038/s12276-022-00764-6. Epub 2022 Jun 7. Exp Mol Med. 2022. PMID: 35672449 Free PMC article.

146

The efficiency and safety of alendronate versus teriparatide for treatment glucocorticoid-induced osteoporosis: A meta-analysis and systematic review of randomized controlled trials.

Liu ZM, Zhang M, Zong Y, Zhang D, Shen ZB, Guan XQ, Yin F. Liu ZM, et al. PLoS One. 2022 May 31;17(5):e0267706. doi: 10.1371/journal.pone.0267706. eCollection 2022. PLoS One. 2022. PMID: 35639783 Free PMC article.

147

Bone Health in Children with Rheumatic Disorders: Focus on Molecular Mechanisms, Diagnosis, and Management.

Di Marcello F, Di Donato G, d'Angelo DM, Breda L, Chiarelli F. Di Marcello F, et al. Int J Mol Sci. 2022 May 20;23(10):5725. doi: 10.3390/ijms23105725. Int J Mol Sci. 2022. PMID: 35628529 Free PMC article. Review.

148

Zuo-Gui-Wan Aqueous Extract Ameliorates Glucocorticoid-Induced Spinal Osteoporosis of Rats by Regulating let-7f and Autophagy.

Shen G, Shang Q, Zhang Z, Zhao W, Chen H, Mijiti I, Chen G, Yu X, Yu F, Zhang P, He J, Zhang X, Tang J, Cui J, Liang D, Zeng L, Ren H, Jiang X. Shen G, et al. Front Endocrinol (Lausanne). 2022 May 3;13:878963. doi: 10.3389/fendo.2022.878963. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35592785 Free PMC article.

149

An inconvenient status in anti-osteoporotic treatment process: corticosteroid use.

Öztürk E, Çiğiloğlu A, Çakmak G, Öztürk ZA. Öztürk E, et al. Rev Assoc Med Bras (1992). 2022 May;68(5):636-640. doi: 10.1590/1806-9282.20211368. Rev Assoc Med Bras (1992). 2022. PMID: 35584488 Free article.

150

A randomized trial of alendronate as prophylaxis against loss in bone mineral density following lymphoma treatment.

Jensen P, Jakobsen LH, Bøgsted M, Baech J, Lykkeboe S, Severinsen MT, Vestergaard P, El-Galaly TC. Jensen P, et al. Blood Adv. 2022 Apr 26;6(8):2549-2556. doi: 10.1182/bloodadvances.2021006330. Blood Adv. 2022. PMID: 35045567 Free PMC article. Clinical Trial.

151

Bad to the Bone: The Effects of Therapeutic Glucocorticoids on Osteoblasts and Osteocytes.

Gado M, Baschant U, Hofbauer LC, Henneicke H. Gado M, et al. Front Endocrinol (Lausanne). 2022 Mar 31;13:835720. doi: 10.3389/fendo.2022.835720. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35432217 Free PMC article. Review.

152

Secondary Osteoporosis.

Ebeling PR, Nguyen HH, Aleksova J, Vincent AJ, Wong P, Milat F. Ebeling PR, et al. Endocr Rev. 2022 Mar 9;43(2):240-313. doi: 10.1210/endrev/bnab028. Endocr Rev. 2022. PMID: 34476488 Free article.

153

Status of Glucocorticoid-Induced Osteoporosis Preventive Care in Korea: A Retrospective Cohort Study on the Korean National Health Insurance Service Database.

Song BW, Kim AR, Kim MA, Kim HS, Lee SG. Song BW, et al. Medicina (Kaunas). 2022 Feb 21;58(2):324. doi: 10.3390/medicina58020324. Medicina (Kaunas). 2022. PMID: 35208647 Free PMC article.

154

The Impact of High Dose Glucocorticoids on Bone Health and Fracture Risk in Systemic Vasculitides.

Box CD, Cronin O, Hauser B. Box CD, et al. Front Endocrinol (Lausanne). 2022 Feb 16;13:806361. doi: 10.3389/fendo.2022.806361. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35250864 Free PMC article. Review.

155

Glucocorticoids Are Not Associated with Bone Mineral Density in Patients with Polymyalgia Rheumatica, Giant Cell Arteritis and Other Vasculitides-Cross-Sectional Baseline Analysis of the Prospective Rh-GIOP Cohort.

Palmowski A, Wiebe E, Muche B, Hermann S, Dejaco C, Matteson EL, Buttgereit F. Palmowski A, et al. Cells. 2022 Feb 4;11(3):536. doi: 10.3390/cells11030536. Cells. 2022. PMID: 35159345 Free PMC article.

156

Benzofuran pyran hybrid prevents glucocorticoid induced osteoporosis in mice via modulation of canonical Wnt/β-catenin signaling.

Tripathi AK, Rai D, Kothari P, Kushwaha P, Sashidhara KV, Trivedi R. Tripathi AK, et al. Apoptosis. 2022 Feb;27(1-2):90-111. doi: 10.1007/s10495-021-01702-z. Epub 2022 Feb 2. Apoptosis. 2022. PMID: 35107658 Free PMC article.

157

Osteoporosis Due to Hormone Imbalance: An Overview of the Effects of Estrogen Deficiency and Glucocorticoid Overuse on Bone Turnover.

Cheng CH, Chen LR, Chen KH. Cheng CH, et al. Int J Mol Sci. 2022 Jan 25;23(3):1376. doi: 10.3390/ijms23031376. Int J Mol Sci. 2022. PMID: 35163300 Free PMC article. Review.

158

Distinct Glucocorticoid Receptor Actions in Bone Homeostasis and Bone Diseases.

Lee S, Krüger BT, Ignatius A, Tuckermann J. Lee S, et al. Front Endocrinol (Lausanne). 2022 Jan 10;12:815386. doi: 10.3389/fendo.2021.815386. eCollection 2021. Front Endocrinol (Lausanne). 2022. PMID: 35082759 Free PMC article. Review.

159

Glucocorticoids Increase Fracture Risk and Fracture Prevalence Independently from Bone Mineral Density and Clinical Risk Factors: Results from the Gliwice Osteoporosis (GO) Study.

Pluskiewicz W, Adamczyk P, Drozdzowska B. Pluskiewicz W, et al. Horm Metab Res. 2022 Jan;54(1):20-24. doi: 10.1055/a-1700-5007. Epub 2022 Jan 5. Horm Metab Res. 2022. PMID: 34986496 Free article.

160

Animal Model for Glucocorticoid Induced Osteoporosis: A Systematic Review from 2011 to 2021.

Xavier A, Toumi H, Lespessailles E. Xavier A, et al. Int J Mol Sci. 2021 Dec 29;23(1):377. doi: 10.3390/ijms23010377. Int J Mol Sci. 2021. PMID: 35008803 Free PMC article.

161

When to Start and Stop Bone-Protecting Medication for Preventing Glucocorticoid-Induced Osteoporosis.

Hayes KN, Baschant U, Hauser B, Burden AM, Winter EM. Hayes KN, et al. Front Endocrinol (Lausanne). 2021 Dec 15;12:782118. doi: 10.3389/fendo.2021.782118. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34975756 Free PMC article. Review.

162

Guideline-based Treatment of Glucocorticoid-induced Osteoporosis in Patients with Rheumatoid Arthritis: A Retrospective Study with the AORA Registry.

Kawano T, Miyakoshi N, Tsuchie H, Kashiwagura T, Kobayashi M, Aonuma H, Sugimura Y, Shimada Y. Kawano T, et al. Acta Med Okayama. 2021 Dec;75(6):699-704. doi: 10.18926/AMO/62809. Acta Med Okayama. 2021. PMID: 34955537 Free article.

163

Osteoporotic Fractures and Vertebral Body Reshaping in Children With Glucocorticoid-treated Rheumatic Disorders.

Ward LM, Ma J, Robinson ME, Scharke M, Ho J, Houghton K, Huber A, Scuccimarri R, Barsalou J, Roth J, Shenouda N, Matzinger MA, Lentle B, Jaremko JL, Koujok K, Watanabe Duffy K, Stein R, Sbrocchi AM, Rodd C, Miettunen PM, LeBlanc CMA, Larche M, Jurencak R, Cummings EA, Couch R, Cabral DA, Atkinson S, Alos N, Sykes E, Konji VN, Rauch F, Siminoski K, Lang B. Ward LM, et al. J Clin Endocrinol Metab. 2021 Nov 19;106(12):e5195-e5207. doi: 10.1210/clinem/dgab494. J Clin Endocrinol Metab. 2021. PMID: 34232311 Free article.

164

Zoledronic Acid vs Placebo in Pediatric Glucocorticoid-induced Osteoporosis: A Randomized, Double-blind, Phase 3 Trial.

Ward LM, Choudhury A, Alos N, Cabral DA, Rodd C, Sbrocchi AM, Taback S, Padidela R, Shaw NJ, Hosszu E, Kostik M, Alexeeva E, Thandrayen K, Shenouda N, Jaremko JL, Sunkara G, Sayyed S, Aftring RP, Munns CF. Ward LM, et al. J Clin Endocrinol Metab. 2021 Nov 19;106(12):e5222-e5235. doi: 10.1210/clinem/dgab458. J Clin Endocrinol Metab. 2021. PMID: 34228102 Free article. Clinical Trial.

165

The Use of Herbal Medicines for the Prevention of Glucocorticoid-Induced Osteoporosis.

Zhang L, Li X, Ying T, Wang T, Fu F. Zhang L, et al. Front Endocrinol (Lausanne). 2021 Nov 12;12:744647. doi: 10.3389/fendo.2021.744647. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34867788 Free PMC article. Review.

166

Fracture Risk and Its Prevention Patterns in Korean Patients with Polymyalgia Rheumatica: a Retrospective Cohort Study.

Nam B, Sung YK, Choi CB, Kim TH, Jun JB, Bae SC, Yoo DH, Cho SK. Nam B, et al. J Korean Med Sci. 2021 Oct 25;36(41):e263. doi: 10.3346/jkms.2021.36.e263. J Korean Med Sci. 2021. PMID: 34697929 Free PMC article.

167

Loss of glucocorticoid rhythm induces an osteoporotic phenotype in female mice.

Schilperoort M, Kroon J, Kooijman S, Smit AE, Gentenaar M, Mletzko K, Schmidt FN, van Ruijven L, Busse B, Pereira AM, Appelman-Dijkstra NM, Bravenboer N, Rensen PCN, Meijer OC, Winter EM. Schilperoort M, et al. Aging Cell. 2021 Oct;20(10):e13474. doi: 10.1111/acel.13474. Epub 2021 Sep 30. Aging Cell. 2021. PMID: 34592793 Free PMC article.

168

Four-Year Teriparatide Followed by Denosumab vs. Continuous Denosumab in Glucocorticoid-Induced Osteoporosis Patients With Prior Bisphosphonate Treatment.

Hirooka Y, Nozaki Y, Okuda S, Sugiyama M, Kinoshita K, Funauchi M, Matsumura I. Hirooka Y, et al. Front Endocrinol (Lausanne). 2021 Sep 27;12:753185. doi: 10.3389/fendo.2021.753185. eCollection 2021. Front Endocrinol (Lausanne). 2021. PMID: 34646240 Free PMC article. Clinical Trial.

169

A Neuroprotective Bovine Colostrum Attenuates Apoptosis in Dexamethasone-Treated MC3T3-E1 Osteoblastic Cells.

Martin-Aragon S, Bermejo-Bescós P, Benedí J, Raposo C, Marques F, Kydonaki EK, Gkiata P, Koutedakis Y, Ntina G, Carrillo AE, Amorim T. Martin-Aragon S, et al. Int J Mol Sci. 2021 Sep 22;22(19):10195. doi: 10.3390/ijms221910195. Int J Mol Sci. 2021. PMID: 34638536 Free PMC article.

170

Pathogenesis of Musculoskeletal Deficits in Children and Adults with Inflammatory Bowel Disease.

Steell L, Gray SR, Russell RK, MacDonald J, Seenan JP, Wong SC, Gaya DR. Steell L, et al. Nutrients. 2021 Aug 23;13(8):2899. doi: 10.3390/nu13082899. Nutrients. 2021. PMID: 34445056 Free PMC article. Review.

171

Lycii radicis cortex inhibits glucocorticoid‑induced bone loss by downregulating Runx2 and BMP‑2 expression.

Lee B, Hong S, Kim M, Kim EY, Park HJ, Jung HS, Kim JH, Sohn Y. Lee B, et al. Int J Mol Med. 2021 Aug;48(2):155. doi: 10.3892/ijmm.2021.4988. Epub 2021 Jun 24. Int J Mol Med. 2021. PMID: 34165156 Free PMC article.

172

Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients.

Cho SK, Kim H, Lee J, Nam E, Lee S, Choi YY, Sung YK. Cho SK, et al. Arthritis Res Ther. 2021 Jul 2;23(1):176. doi: 10.1186/s13075-021-02564-1. Arthritis Res Ther. 2021. PMID: 34215316 Free PMC article. Clinical Trial.

173

Baicalein ameliorates osteoporosis via AKT/FOXO1 signaling.

Cai P, Lu Y, Yin Z, Wang X, Zhou X, Li Z. Cai P, et al. Aging (Albany NY). 2021 Jul 1;13(13):17370-17379. doi: 10.18632/aging.203227. Epub 2021 Jul 1. Aging (Albany NY). 2021. PMID: 34198266 Free PMC article.

174

WNT7B overexpression rescues bone loss caused by glucocorticoids in mice.

Chen H, Song F, Long F. Chen H, et al. FASEB J. 2021 Jul;35(7):e21683. doi: 10.1096/fj.202100151RR. FASEB J. 2021. PMID: 34118078 Free PMC article.

175

Arbutin ameliorates glucocorticoid-induced osteoporosis through activating autophagy in osteoblasts.

Zhang Y, Li M, Liu Z, Fu Q. Zhang Y, et al. Exp Biol Med (Maywood). 2021 Jul;246(14):1650-1659. doi: 10.1177/15353702211002136. Epub 2021 Mar 23. Exp Biol Med (Maywood). 2021. PMID: 33757338 Free PMC article.

176

Impact of Anti-Citrullinated Protein Antibodies on Progressive Systemic Bone Mineral Density Loss in Patients With Early Rheumatoid Arthritis After Two Years of Treat-to-Target.

Bugatti S, Bogliolo L, Manzo A, De Stefano L, Delvino P, Motta F, Montecucco C. Bugatti S, et al. Front Immunol. 2021 Jun 14;12:701922. doi: 10.3389/fimmu.2021.701922. eCollection 2021. Front Immunol. 2021. PMID: 34194443 Free PMC article.

177

Short-term glucocorticoid excess blunts abaloparatide-induced increase in femoral bone mass and strength in mice.

Brent MB, Thomsen JS, Brüel A. Brent MB, et al. Sci Rep. 2021 Jun 10;11(1):12258. doi: 10.1038/s41598-021-91729-8. Sci Rep. 2021. PMID: 34112892 Free PMC article.

178

Update on Glucocorticoid Induced Osteoporosis.

Cho SK, Sung YK. Cho SK, et al. Endocrinol Metab (Seoul). 2021 Jun;36(3):536-543. doi: 10.3803/EnM.2021.1021. Epub 2021 Jun 1. Endocrinol Metab (Seoul). 2021. PMID: 34107602 Free PMC article.

179

Corticosteroids and bone health in people with asthma: A systematic review and meta-analysis.

Chalitsios CV, Shaw DE, McKeever TM. Chalitsios CV, et al. Respir Med. 2021 May;181:106374. doi: 10.1016/j.rmed.2021.106374. Epub 2021 Mar 26. Respir Med. 2021. PMID: 33799052 Free article.

180

[Safety aspects of the treatment with glucocorticoids for rheumatoid arthritis].

Keyßer G. Keyßer G. Z Rheumatol. 2021 May;80(4):295-304. doi: 10.1007/s00393-021-00972-x. Epub 2021 Mar 11. Z Rheumatol. 2021. PMID: 33704557 Free PMC article. Review. German.

181

Targeting cellular senescence prevents glucocorticoid-induced bone loss through modulation of the DPP4-GLP-1 axis.

Wang T, Yang L, Liang Z, Wang L, Su F, Wang X, You X, He C. Wang T, et al. Signal Transduct Target Ther. 2021 Apr 7;6(1):143. doi: 10.1038/s41392-021-00528-0. Signal Transduct Target Ther. 2021. PMID: 33824289 Free PMC article. No abstract available.

182

Comment on an article: "Osteoporosis in the age of COVID-19 patients".

Ibrahimagić OĆ, Vujadinović A, Ercegović Z, Kunić S, Smajlović D, Dostović Z. Ibrahimagić OĆ, et al. Osteoporos Int. 2021 Apr;32(4):783-784. doi: 10.1007/s00198-020-05607-6. Epub 2021 Jan 21. Osteoporos Int. 2021. Retraction in: Osteoporos Int. 2021 Sep;32(9):1909. doi: 10.1007/s00198-021-06031-0. PMID: 33479845 Free PMC article. Retracted. No abstract available.

183

Rheumatoid arthritis, bone and drugs: a dangerous interweave.

Minisola S, Pepe J, Cipriani C. Minisola S, et al. Ann Rheum Dis. 2021 Apr;80(4):409-410. doi: 10.1136/annrheumdis-2020-219545. Epub 2021 Jan 17. Ann Rheum Dis. 2021. PMID: 33455919 Free article. No abstract available.

184

Association of Potent and Very Potent Topical Corticosteroids and the Risk of Osteoporosis and Major Osteoporotic Fractures.

Egeberg A, Schwarz P, Harsløf T, Andersen YMF, Pottegård A, Hallas J, Thyssen JP. Egeberg A, et al. JAMA Dermatol. 2021 Mar 1;157(3):275-282. doi: 10.1001/jamadermatol.2020.4968. JAMA Dermatol. 2021. PMID: 33471030 Free PMC article.

185

Low prevalence of bone mineral density testing in patients with systemic lupus erythematosus and glucocorticoid exposure.

Boone JB, Wheless L, Camai A, Tanner SB, Barnado A. Boone JB, et al. Lupus. 2021 Mar;30(3):403-411. doi: 10.1177/0961203320979735. Epub 2020 Dec 13. Lupus. 2021. PMID: 33307984 Free PMC article.

186

Connexin Gap Junctions and Hemichannels Link Oxidative Stress to Skeletal Physiology and Pathology.

Hua R, Zhang J, Riquelme MA, Jiang JX. Hua R, et al. Curr Osteoporos Rep. 2021 Feb;19(1):66-74. doi: 10.1007/s11914-020-00645-9. Epub 2021 Jan 6. Curr Osteoporos Rep. 2021. PMID: 33403446 Free PMC article. Review.

187

Effects of mechanical stimuli on structure and organization of bone nanocomposites in rats with glucocorticoid-induced osteoporosis.

Kostyshyn NM, Gzhegotskyi MR, Kostyshyn LP, Mudry SI. Kostyshyn NM, et al. Endocr Regul. 2021 Jan 29;55(1):42-51. doi: 10.2478/enr-2021-0006. Endocr Regul. 2021. PMID: 33600670 Free article.

188

PECULIARITIES OF BONE MINERAL DENSITY IN WOMEN OF DIFFERENT REPRODUCTIVE AGE WITH SYSTEMIC LUPUS ERYTHEMATOSUS.

Shevchuk SV, Denyshchych LP, Marynych LI, Kuvikova IP, Kurilenko IV, Shevchuk OV. Shevchuk SV, et al. Wiad Lek. 2021;74(2):303-309. Wiad Lek. 2021. PMID: 33813491 Free article.

189

Potential mechanisms linking psychological stress to bone health.

Ng JS, Chin KY. Ng JS, et al. Int J Med Sci. 2021 Jan 1;18(3):604-614. doi: 10.7150/ijms.50680. eCollection 2021. Int J Med Sci. 2021. PMID: 33437195 Free PMC article. Review.

190

A pragmatic proposal for triaging DXA testing during the COVID-19 global pandemic.

Sapkota HR, Nune A, Bateman J, Venkatachalam S. Sapkota HR, et al. Osteoporos Int. 2021 Jan;32(1):1-6. doi: 10.1007/s00198-020-05722-4. Epub 2020 Nov 4. Osteoporos Int. 2021. PMID: 33146750 Free PMC article.

191

Glucocorticoid-Induced Osteoporosis: Why Kids Are Different.

Ward LM. Ward LM. Front Endocrinol (Lausanne). 2020 Dec 16;11:576. doi: 10.3389/fendo.2020.00576. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33391179 Free PMC article. Review.

192

Efficacy and safety of 18 anti-osteoporotic drugs in the treatment of patients with osteoporosis caused by glucocorticoid: A network meta-analysis of randomized controlled trials.

Liu Z, Zhang M, Shen Z, Ke J, Zhang D, Yin F. Liu Z, et al. PLoS One. 2020 Dec 16;15(12):e0243851. doi: 10.1371/journal.pone.0243851. eCollection 2020. PLoS One. 2020. PMID: 33326444 Free PMC article.

193

The critical role of T cells in glucocorticoid-induced osteoporosis.

Song L, Cao L, Liu R, Ma H, Li Y, Shang Q, Zheng Z, Zhang L, Zhang W, Han Y, Zhang X, Yang H, Wang Y, Melino G, Shao C, Shi Y. Song L, et al. Cell Death Dis. 2020 Dec 14;12(1):45. doi: 10.1038/s41419-020-03249-4. Cell Death Dis. 2020. PMID: 33414409 Free PMC article.

194

Linking glucocorticoid-induced osteoporosis to osteoimmunology.

von Gunten S, Simon HU. von Gunten S, et al. Cell Death Dis. 2020 Dec 14;11(12):1026. doi: 10.1038/s41419-020-03250-x. Cell Death Dis. 2020. PMID: 33311437 Free PMC article. No abstract available.

195

Evaluation of hematology, general serum biochemistry, bone turnover markers and bone marrow cytology in a glucocorticoid treated ovariectomized sheep model for osteoporosis research.

Coelho CA, Bordelo JP, Camassa JA, Barros VA, Babo PS, Gomes ME, Reis RL, Azevedo JT, Requicha JF, FaÍsca P, Carvalho PP, Viegas CA, Dias IR. Coelho CA, et al. An Acad Bras Cienc. 2020 Dec 7;92(4):e20200435. doi: 10.1590/0001-3765202020200435. eCollection 2020. An Acad Bras Cienc. 2020. PMID: 33295580 Free article.

196

Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007-2017.

Lindner L, Callhoff J, Alten R, Krause A, Ochs W, Zink A, Albrecht K. Lindner L, et al. Rheumatol Int. 2020 Dec;40(12):2005-2012. doi: 10.1007/s00296-020-04593-6. Epub 2020 May 6. Rheumatol Int. 2020. PMID: 32377959 Free PMC article.

197

COL3A1, COL6A3, and SERPINH1 Are Related to Glucocorticoid-Induced Osteoporosis Occurrence According to Integrated Bioinformatics Analysis.

Li L, Yang M, Jin A. Li L, et al. Med Sci Monit. 2020 Oct 1;26:e925474. doi: 10.12659/MSM.925474. Med Sci Monit. 2020. PMID: 32999266 Free PMC article.

198

The low-expression programming of 11β-HSD2 mediates osteoporosis susceptibility induced by prenatal caffeine exposure in male offspring rats.

Xiao H, Wu Z, Li B, Shangguan Y, Stoltz JF, Magdalou J, Chen L, Wang H. Xiao H, et al. Br J Pharmacol. 2020 Oct;177(20):4683-4700. doi: 10.1111/bph.15225. Epub 2020 Aug 20. Br J Pharmacol. 2020. PMID: 32757222 Free PMC article.

199

Improved Glucocorticoid Receptor Ligands: Fantastic Beasts, but How to Find Them?

Van Moortel L, Gevaert K, De Bosscher K. Van Moortel L, et al. Front Endocrinol (Lausanne). 2020 Sep 24;11:559673. doi: 10.3389/fendo.2020.559673. eCollection 2020. Front Endocrinol (Lausanne). 2020. PMID: 33071974 Free PMC article. Review.

200

Gumi Bao decoction regulates bone metabolism-related mRNA expression in glucocorticoid-induced osteoporosis in rats.

Feng H, Gong Z, Liang G, Shen X, Cheng J, Su F, Yang L, Liu H. Feng H, et al. Ann Palliat Med. 2020 Sep;9(5):3213-3221. doi: 10.21037/apm-20-1340. Ann Palliat Med. 2020. PMID: 33065783 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

571 results

Results by year

Search Page

Filters

My Custom Filters

Results by year

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

571 results

Results by year